"
Team:Aachen/Attributions
From 2014.igem.org
(→Team Introduction) |
(→Team Introduction) |
||
| Line 95: | Line 95: | ||
<b> Michael Osthege </b> | <b> Michael Osthege </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 107: | Line 107: | ||
<b> Florian Gohr </b> | <b> Florian Gohr </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 119: | Line 119: | ||
<b> Arne Zimmermann </b> | <b> Arne Zimmermann </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology M.Sc. </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 131: | Line 131: | ||
<b> Nina Bailly </b> | <b> Nina Bailly </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 143: | Line 143: | ||
<b> Vera Alexandrova </b> | <b> Vera Alexandrova </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Biology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 155: | Line 155: | ||
<b> Philipp Demling </b> | <b> Philipp Demling </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 167: | Line 167: | ||
<b> René Hanke </b> | <b> René Hanke </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 179: | Line 179: | ||
<b> Patrick Opdenstein </b> | <b> Patrick Opdenstein </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 191: | Line 191: | ||
<b> Björn Peeters </b> | <b> Björn Peeters </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Computational Engineering Science </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 204: | Line 204: | ||
<b> Eshani Sood </b> | <b> Eshani Sood </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Biomedical Engineering </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 216: | Line 216: | ||
<b> Markus Joppich </b> aka <i>iMJ</i> | <b> Markus Joppich </b> aka <i>iMJ</i> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Computer Science </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 228: | Line 228: | ||
<b> Ansgar Niemöller </b> | <b> Ansgar Niemöller </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Computational Engineering Science </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 240: | Line 240: | ||
<b> Julia Plum </b> | <b> Julia Plum </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Biology and Business Administration </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 252: | Line 252: | ||
<b> Stefan Reinhold </b> | <b> Stefan Reinhold </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Molecular and Applied Biotechnology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 264: | Line 264: | ||
<b> Anna Schechtel </b> | <b> Anna Schechtel </b> | ||
<br/><br/> | <br/><br/> | ||
| - | + | <i> Biology </i> | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
Revision as of 02:34, 7 October 2014
|
Prof. Blank focuses in his research on fundamental and applied aspects of microbial metabolism. Of specific interest is the interaction between the metabolic network and the introduced genetic and environmental perturbations. The research on in silico/in vivo metabolic network operation is aimed at a deeper understanding of cell function, with the ultimate goal of rational cell engineering.
In his teaching, Prof. Blank focuses on the integration of biological concepts with the tools from bioinformatics and engineering. He believes that a sound knowledge base in the life sciences is key for creative and thus successful work in the areas of Metabolic Engineering and Synthetic Biology. Read more about Prof. Blank's work on the 
Prof. Wiechert's main area of work lies within the field of applied systems bio(techno)logy of microorganisms with a special focus on methodological developments for quantitative biology. Characteristics of his research work are a close integration of experimental and theoretical work within multi disciplinary projects. As the head of the Systems Biotechnology research division at Jülich Research Centre, he is developing methods for quantitative metabolomics, fluxomics and proteomics including model based mathematical methods for experimental design, parameter estimation, and process optimization in biotechnological systems. Future work will also incorporate micro fluidic methods for single cell analysis. In general, all research results are used to drive forward the process of gaining knowledge in the course of an iterative improvement of industrial production systems. This proceeds in close cooperation of all working groups at the IBG-1. Together with industrial partners also diverse examples from industry are investigated and further developed. Read more about Prof. Wiechert's work on the 
The Schwaneberg Group seeks to be at the research frontier in the interdisciplinary field of directed protein evolution by developing novel methods for generating diversity at the gene level, analyzing consequence of mutational biases on the protein level and developing novel high-throughput screening systems that will ultimately lead to tailored-biocatalysts for significant applications in industry. They train students in the cutting edge technologies of laboratory evolution, biocatalyst engineering and high throughput screening methodologies. The Schwaneberg Group believes in integrating fundamental principles of protein design with environmental awareness in their research and seeks to promote international scientific collaborations. Read more about Prof. Schwaneberg and his work on the 
